RBC Capital Raises Target Price for Abbott to $130
Target(TGT) Gurufocus·2024-10-09 08:51
RBC Capital has recently adjusted its outlook on Abbott Laboratories (ABT, Financial), increasing its target price from $125 to $130. The firm continues to maintain an "Outperform" rating for the company, indicating a strong confidence in its potential for growth in the market. ...